DekaBank Deutsche Girozentrale’s Maravai LifeSciences MRVI Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-44,000	Closed	-$411K	–	1272
2025 Q4	$411K	Hold	44,000	–	–	﹤0.01%	1038
2025 Q3	$123K	Hold	44,000	–	–	﹤0.01%	1202
2025 Q2	$108K	Hold	44,000	–	–	﹤0.01%	1215
2025 Q1	$103K	Hold	44,000	–	–	﹤0.01%	1206
2024 Q4	$228K	Hold	44,000	–	–	﹤0.01%	1128
2024 Q3	$363K	Hold	44,000	–	–	﹤0.01%	1072
2024 Q2	$309K	Hold	44,000	–	–	﹤0.01%	1083
2024 Q1	$371K	Hold	44,000	–	–	﹤0.01%	1056
2023 Q4	$292K	Hold	44,000	–	–	﹤0.01%	1140
2023 Q3	$419K	Hold	44,000	–	–	﹤0.01%	1052
2023 Q2	$547K	Hold	44,000	–	–	﹤0.01%	1006
2023 Q1	$584K	Hold	44,000	–	–	﹤0.01%	985
2022 Q4	$611K	Sell	44,000 -689	-2%	-$10.8K	﹤0.01%	994
2022 Q3	$1.11M	Hold	44,689	–	–	﹤0.01%	849
2022 Q2	$1.22M	Hold	44,689	–	–	﹤0.01%	826
2022 Q1	$1.59M	Sell	44,689 -1,617	-3%	-$54.2K	﹤0.01%	812
2021 Q4	$1.88M	Buy	46,306 +45,617	+6,621%	+$1.85M	﹤0.01%	791
2021 Q3	$33K	Hold	689	–	–	﹤0.01%	1347
2021 Q2	$29K	Buy	+689	New	+$26.7K	﹤0.01%	1362

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DekaBank Deutsche Girozentrale's MRVI Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Maravai LifeSciences (MRVI) in Q1 2026, closing a stake of 44,000 shares — an estimated $411K sold.

DekaBank Deutsche Girozentrale first reported a position in MRVI in Q2 2021 and held it in 19 quarters. The position peaked at $1.88M in Q4 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Maravai LifeSciences position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 44,000 Maravai LifeSciences shares in Q1 2026, an estimated $411K.
DekaBank Deutsche Girozentrale first reported a position in Maravai LifeSciences in Q2 2021 and held it in 19 quarters.
DekaBank Deutsche Girozentrale's Maravai LifeSciences position peaked at $1.88M in Q4 2021.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.